Price
No data yet.
Social Signal Score
Revenue
$70.17M+78846446.07%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Bruce Peatey
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 301
- Beta
- 1.33
- Country
- AU
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 12.50
Financials
Revenue
$70.17M+78846446.1%Net Income
$3.0KEBITDA
$3.35MFree Cash Flow
$-1.62MEPS (diluted)
$0.00Shares Outstanding (diluted)
698.22M+167.2%Operating Expenses
$19.47MCash & Debt
$29.25MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $127.24M | $13.21M | $0.02 |
| 2024 | $103.19M | $5.26M | $0.01 |
| 2023 | $65.24M | $-4.92M | $-0.01 |
| 2022 | $41.44M | $-1.19M | $-0.00 |
| 2021 | $29.16M | $-4.61M | $-0.01 |
| 2020 | $22.16M | $-4.19M | $-0.01 |
| 2019 | $14.04M | $-3.19M | $-0.00 |
| 2018 | $6.55M | $-5.97M | $-0.01 |
| 2017 | $3.62M | $-5.01M | $-0.01 |
| 2016 | $3.28M | $-3.06M | $-0.01 |
| 2015 | $22.3K | $-1.30M | $-0.00 |
| 2014 | $60.2K | $-2.94M | $-0.01 |
| 2013 | $112.6K | $-1.49M | $-0.00 |
| 2012 | $0.00 | $-2.70M | $-0.01 |
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $0.03
- Implied price
- $0.51
- Return from $0.76
- -7.8% a year
To earn 15.0% a year on these assumptions you'd need to buy at $0.25 — -66.8% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -2.0% | -22.8% | -19.3% | -16.3% | -13.7% | -11.3% |
| 3.0% | -18.9% | -15.2% | -12.0% | -9.3% | -6.8% |
| 8.0% | -14.9% | -11.1% | -7.8% | -4.9% | -2.3% |
| 13.0% | -11.0% | -6.9% | -3.5% | -0.5% | 2.2% |
| 18.0% | -7.1% | -2.8% | 0.8% | 3.9% | 6.8% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
120Social Signal Score
Mentions (1)
- Newsseekingalpha.com·5h ago·Positive
PolyNovo Limited (CALZF) Q4 2026 Earnings Call Transcript PolyNovo Limited (CALZF) Q4 2026 Earnings Call Transcript
View source ↗
Earnings
Tue, Mar 2(in 6 months)
Consensus estimate $0.00 per share
Typical surprise +84.0% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Jul 22$0.00 vs $0.01miss
- Mon, Aug 25$0.01 vs $0.01beat
- Wed, Feb 26$0.00 vs $0.00beat
- Fri, Aug 23$0.00 vs $0.01miss
- Thu, Aug 24$-0.00 vs $-0.01beat
Estimates and results for CALZF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.